Heart failure affects millions of people every year and puts growing pressure on care. Inefficient treatments result in reuptakes and high costs, with €577 million per year in the Netherlands. The HeartLinQ project offers a solution. This portable device monitors heart failure patients for 14 days and measures biomarkers such as bioimpedance and hemodynamic changes. Data is sent via Bluetooth to a hub, where algorithms generate clinical information for doctors. The project supports a personalized care approach, lower care burden and cost savings, and contributes to a healthier population in the South of the Netherlands.